Delivery Order SPE2DB22D2214-SPE2DB23FS4RH
Award Date 5/3/23
Potential Completion Date 5/4/23
Potential Value $15K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of Lidocaine 5% patches to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a Firm Fixed Price Delivery Order valued at $1,021.06. The contract has an ultimate completion date of August 21, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is for the delivery of Lidocaine 5% patches to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,348.88 and an ultimate completion date of February 1, 2024. It is a firm-fixed-price delivery order contract, with no set-aside designation, indicating open competition....
- This federal contract award is for the delivery of Lidocaine 5% patches to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $1,804.18, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of May 1, 2024. The contract is not associated with any...
- This federal contract award is for the delivery of Lidocaine 5% patches to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,852.85, is a firm fixed-price delivery order with a completion date of July 26, 2022. The contract was awarded on July 25, 2022, and does not have a set-aside designation, indicating...
- This federal contract award is for the delivery of Lidocaine 5% patches to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, and is valued at $12,529.66. The contract has an ultimate completion date of May 7, 2024. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which is the parent company. This contract is a delivery order under a larger Indefinite Delivery Contract...
- This federal contract award is for the delivery of Lidocaine 5% Patches to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is a Delivery Order with a Firm Fixed Price of $8,916.79 and an ultimate completion date of January 13, 2022. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
- This federal contract award is for the delivery of Lidocaine 5% Patch 30s to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,348.34, is a delivery order with a firm fixed price. There is no set-aside designation, indicating open competition. Amerisourcebergen is the subsidiary of the parent company, Cencora, Inc., which does business as Amerisourcebergen....
- This federal contract award is for the delivery of Lidocaine 5% Patches to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distribution company. The contract is a Delivery Order with a Firm Fixed Price of $4,355.76 and an Ultimate Completion Date of May 22, 2023. The contract is not designated with any set-aside requirements, indicating open competition....
- This federal contract award to Amerisourcebergen Drug Corp, a division of parent company Cencora, Inc., is for the delivery of Lidocaine 5% Patches in the amount of $2,673.17. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, with an ultimate completion date of May 19, 2023. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award is for the delivery of Lidocaine 5% Patches to the Defense Logistics Agency (DLA). The contract, valued at $11,861.25, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of January 30, 2024 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside and was awarded through open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...